|
University of Washington ACTU Seeks Participants for Two New Studies
Spring 2003 University of Washington
AIDS Clinical Trials Unit 325 9th Avenue, Second Floor (2West Clinic) Seattle, WA 98104 206.731.3184 actu@u.washington.edu http://depts.washington.edu/actu
Latest HIV/AIDS Clinical TrialsNeuropathy StudyOpen-label, Dose-escalation, Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy Pilot StudyPurpose: to see if taking acetyl-L-carnitine (ALC), an investigational substance, reduces neuropathy (numbness, pain, or tingling in legs and feet) in people who are taking anti-HIV drugs ddC, or ddI or d4T. Length: 24 weeks Contact: Alyssa Spingola or Lori Cray at (206) 731-3184 (spingola@u.washington.edu)
Semen StudyCrossover trial of valganciclovir in persons with HIV-1 infection and HIV and CMV co-shedding in semenPurpose: to evaluate the effectiveness of oral valganciclovir in decreasing the shedding of HIV in semen. Length: 12 weeks after entry Reimbursement: Semen samples are reimbursed at the following rates: $15 for screening samples, $25 for each of the three samples at weeks 2-4, and $40 for each of the samples at weeks 8, 10, 11, and 12. Contact: Leslie Deutsch (206) 543-8299 (leslie@u.washington.edu)
This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Perspective. |